Intas Pharmaceuticals Limited Vildagliptin Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Vildagliptin Export Records India — #3 Exporter, 53 Shipments, $996.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Vildagliptin

India Pharmaceutical Trade Intelligence

$10.2M178 Suppliers87 CountriesHS 30049099

ExportsIndia → FRANCE14.4%India → PORTUGAL10.1%

ImportsTURKEY → India$2110.6B SPAIN → India$164.0B

#1 Supplier: AJANTA PHARMA #1 Buyer: PLANET PHARMA

Intas Pharmaceuticals Limited — Vildagliptin Exporter #3 | $996.7K Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Vildagliptin Exporter Profile

Indian Pharmaceutical Exporter · #3 for Vildagliptin · $996.7K export value · DGFT Verified

Intas Pharmaceuticals Limited is the #3 Indian exporter of Vildagliptin with $996.7K in export value and 53 verified shipments. Intas Pharmaceuticals Limited holds a 9.8% market share in Vildagliptin exports across 7 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Vildagliptin Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Vildagliptin export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Vildagliptin?

Country	Value	Shipments	Share
NETHERLANDS	$289.3K	25	62.0%
POLAND	$78.9K	8	16.9%
ITALY	$72.6K	4	15.6%
UNITED KINGDOM	$23.2K	3	5.0%
FRANCE

Who Are the Top Buyers of Vildagliptin from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
BROCACEF NL DUTCH	NETHERLANDS	$85.9K	7
BROCACEF NL : DUTCH	NETHERLANDS	$73.9K	5
ACCORD HEALTHCARE ITALIA SRL.	ITALY	$66.2K	3
BROCACEF NL HUB	NETHERLANDS	$41.1K	4
ACCORD HEALTHCARE POLSKA SP. Z O.O.	POLAND	$30.8K	3
BROCACEF NL:EU HUB	NETHERLANDS	$27.6K	1
BROCACEF NL : LOCAL	NETHERLANDS	$27.4K	1
ACCORD HEALTHCARE POLSKA SP. Z.O.O.	POLAND	$26.9K	3
ACCORD UK	UNITED KINGDOM	$23.2K	3
BROCACEF NL : HUB	NETHERLANDS	$21.8K	3

Intas Pharmaceuticals Limited supplies Vildagliptin to 19 buyers globally. The largest buyer is BROCACEF NL DUTCH (NETHERLANDS), followed by BROCACEF NL : DUTCH (NETHERLANDS) and ACCORD HEALTHCARE ITALIA SRL. (ITALY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Vildagliptin Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUG&MED:VILDAGLIPTIN 50MG 4X14T(	$66.2K	3
PHARMA DRUGS & MEDI VILDAGLIPTIN 50MG 2X14T(ACCORD-NL AS PER INVOICE	$64.5K	2
PHARMA DRUGS & MEDI VILDAGLIPTIN 50MG 4X	$50.2K	6
PHA.DRU & MEDI, VILDAGLIPTIN 50MG 2X14T(ACCORD-NL EACH UNCOATED TABLET CONTAINSVILDAGLIPTIN 50 MG, 18731X2X14T	$50.0K	1
PHARMA DRUGS MEDI VILDAGLIPTIN 50MG 9X10T ACCORD DK NO AS PER INVOICE	$39.4K	2
PHARM DRUG&MED:VILDAGLI METFOR 50/1000MG6X10T(ACO-EELV)EACH FILM COATED TABLETCONT:VILDAGLIPTIN # 50 MG METFORMIN HYDR	$27.6K	1
PHARM DRUG&MED:VILDAGLI METFOR 50/1000MG6X10T(ACO-NL)EACH FILM COATED TABLET CONT:VILDAGLIPTIN 50MG METFORMIN HYDROCHLO	$27.4K	1
PHARMA DRUG&MED: VILDAGLIPTIN 50MG 2X14TACCORD-NL Each Uncoated tablet Contains: Vildagliptin 50 mg	$26.5K	2
PHARMA DRUGS & MEDI VILDAGLIPTIN 50MG 9X	$21.8K	3
PHARM DRUG&MED:VILDAGLI METFOR 50/1000MG3X10T(ACO-CZ)ECH FLM CTD TAB CONT-VILDAGLIPTIN # 50 MG METFORMIN (ASPERINV)	$17.5K	1

Intas Pharmaceuticals Limited exports 35 distinct Vildagliptin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUG&MED:VILDAGLIPTIN 50MG 4X14T( with 3 shipments worth $66.2K.

How Does Intas Pharmaceuticals Limited Compare to Nearest Vildagliptin Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	AJANTA PHARMA LIMITED	$1.8M	92	9	$19.9K
2	CADILA PHARMACEUTICALS LIMITED	$1.0M	22	1	$46.6K
3	INTAS PHARMACEUTICALS LIMITED ★	$996.7K	53	7	$18.8K
4	EMCURE PHARMACEUTICALS LIMITED	$984.8K	64	4	$15.4K
6	MICRO LABS LIMITED	$494.8K	15	8	$33.0K

Intas Pharmaceuticals Limited ranks #3 among 178 Indian Vildagliptin exporters. Average shipment value of $18.8K compared to the market average of $42.0K. The closest competitors by value are AJANTA PHARMA LIMITED and CADILA PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Vildagliptin Exports?

Port	Shipments	% Share
SAHAR AIR	165	14.4%
SAHAR AIR CARGO ACC (INBOM4)	127	11.1%
DELHI AIR	71	6.2%
NHAVA SHEVA SEA (INNSA1)	59	5.1%
DELHI AIR CARGO ACC (INDEL4)	59	5.1%
Bombay Air	57	5.0%
JNPT/ NHAVA SHEVA SEA	46	4.0%
MUNDRA SEA (INMUN1)	43	3.7%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Vildagliptin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Vildagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 56 individual customs records matching Intas Pharmaceuticals Limited exporting Vildagliptin, covering 35 formulations to 7 countries via 19 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 87+ countries, 304+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Vildagliptin

Vildagliptin

Intas Pharmaceuticals Limited — Vildagliptin Exporter Profile

Intas Pharmaceuticals Limited — Vildagliptin Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Vildagliptin?

Who Are the Top Buyers of Vildagliptin from Intas Pharmaceuticals Limited?

What Is India's Total Vildagliptin Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Vildagliptin Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Vildagliptin Exporters?

What Vildagliptin Formulations Does Intas Pharmaceuticals Limited Export?

How Does Intas Pharmaceuticals Limited Compare to Nearest Vildagliptin Exporters?

Which Indian Ports Ship Vildagliptin Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Vildagliptin Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Vildagliptin Export Data from Intas Pharmaceuticals Limited

Vildagliptin Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source